Bevacizumab in Advanced Hepatocellular Carcinoma

NCT00162669 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: bevacizumab

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]